258 related articles for article (PubMed ID: 22491208)
1. Development of a microemulsion-based formulation to improve the availability of poorly water-soluble drug.
Abd-Allah FI; Dawaba HM; Ahmed AM
Drug Discov Ther; 2010 Aug; 4(4):257-66. PubMed ID: 22491208
[TBL] [Abstract][Full Text] [Related]
2. Microemulsion system with improved loading of piroxicam: a study of microstructure.
Nazar MF; Khan AM; Shah SS
AAPS PharmSciTech; 2009; 10(4):1286-94. PubMed ID: 19876741
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of antitubercular drug isoniazid in pharmaceutically accepted microemulsion: effect on microstructure and physical parameters.
Mehta SK; Kaur G; Bhasin KK
Pharm Res; 2008 Jan; 25(1):227-36. PubMed ID: 17577642
[TBL] [Abstract][Full Text] [Related]
4. In-vitro and in-vivo comparison of T-OA microemulsions and solid dispersions based on EPDC.
Hou P; Cao S; Ni J; Zhang T; Cai Z; Liu J; Wang Y; Wang P; Lei H; Liu Y
Drug Dev Ind Pharm; 2015 Feb; 41(2):263-71. PubMed ID: 24256156
[TBL] [Abstract][Full Text] [Related]
5. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
Nikumbh KV; Sevankar SG; Patil MP
Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
[TBL] [Abstract][Full Text] [Related]
6. Transdermal delivery of piroxicam using microemulsions.
Park ES; Cui Y; Yun BJ; Ko IJ; Chi SC
Arch Pharm Res; 2005 Feb; 28(2):243-8. PubMed ID: 15789759
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and in vitro evaluation of microemulsion of raloxifene hydrochloride.
Golmohammadzadeh S; Farhadian N; Biriaee A; Dehghani F; Khameneh B
Drug Dev Ind Pharm; 2017 Oct; 43(10):1619-1625. PubMed ID: 28489426
[TBL] [Abstract][Full Text] [Related]
8. Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design.
Kawakami K; Yoshikawa T; Moroto Y; Kanaoka E; Takahashi K; Nishihara Y; Masuda K
J Control Release; 2002 May; 81(1-2):65-74. PubMed ID: 11992679
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of microemulsions containing orange oil with water and propylene glycol as hydrophilic components.
Yotsawimonwat S; Okonoki S; Krauel K; Sirithunyalug J; Sirithunyalug B; Rades T
Pharmazie; 2006 Nov; 61(11):920-6. PubMed ID: 17152984
[TBL] [Abstract][Full Text] [Related]
10. Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study.
Shah N; Seth A; Balaraman R; Sailor G; Javia A; Gohil D
Drug Dev Ind Pharm; 2018 Apr; 44(4):687-696. PubMed ID: 29168671
[TBL] [Abstract][Full Text] [Related]
11. Microemulsion formulation of clonixic acid: solubility enhancement and pain reduction.
Lee JM; Park KM; Lim SJ; Lee MK; Kim CK
J Pharm Pharmacol; 2002 Jan; 54(1):43-9. PubMed ID: 11829128
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Tween based microemulsion in the presence of TB drug rifampicin.
Mehta SK; Kaur G; Bhasin KK
Colloids Surf B Biointerfaces; 2007 Oct; 60(1):95-104. PubMed ID: 17646089
[TBL] [Abstract][Full Text] [Related]
13. Formulation, characterization, and in vitro/ex vivo evaluation of quercetin-loaded microemulsion for topical application.
Kajbafvala A; Salabat A; Salimi A
Pharm Dev Technol; 2018 Oct; 23(8):741-750. PubMed ID: 27871215
[TBL] [Abstract][Full Text] [Related]
14. Design of microemulsion system suitable for the oral delivery of poorly aqueous soluble beta-carotene.
Peng C; Svirskis D; Lee SJ; Oey I; Kwak HS; Chen G; Bunt C; Wen J
Pharm Dev Technol; 2018 Sep; 23(7):682-688. PubMed ID: 28125945
[TBL] [Abstract][Full Text] [Related]
15. Microemulsion-Based Topical Hydrogels of Tenoxicam for Treatment of Arthritis.
Goindi S; Narula M; Kalra A
AAPS PharmSciTech; 2016 Jun; 17(3):597-606. PubMed ID: 26285672
[TBL] [Abstract][Full Text] [Related]
16. Formulation of a cosurfactant-free O/W microemulsion using nonionic surfactant mixtures.
Cho YH; Kim S; Bae EK; Mok CK; Park J
J Food Sci; 2008 Apr; 73(3):E115-21. PubMed ID: 18387105
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants.
El Maghraby GM
Int J Pharm; 2008 May; 355(1-2):285-92. PubMed ID: 18243604
[TBL] [Abstract][Full Text] [Related]
18. Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability.
Ghosh PK; Majithiya RJ; Umrethia ML; Murthy RS
AAPS PharmSciTech; 2006 Sep; 7(3):77. PubMed ID: 17025257
[TBL] [Abstract][Full Text] [Related]
19. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug.
Li P; Hynes SR; Haefele TF; Pudipeddi M; Royce AE; Serajuddin AT
J Pharm Sci; 2009 May; 98(5):1750-64. PubMed ID: 18781639
[TBL] [Abstract][Full Text] [Related]
20. Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia).
Ali J; Akhtar N; Sultana Y; Baboota S; Ahuja A
Methods Find Exp Clin Pharmacol; 2008 May; 30(4):277-85. PubMed ID: 18773122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
